Literature DB >> 3295160

Risk factors for development of hemolytic uremic syndrome during shigellosis.

T Butler, M R Islam, M A Azad, P K Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3295160     DOI： 10.1016/s0022-3476(87)80405-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  25 in total

1.  Escherichia coli infections and hemolytic-uremic syndrome.

Authors:  N Cimolai
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

2.  Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1.

Authors:  V Pozsgay; C Chu; L Pannell; J Wolfe; J B Robbins; R Schneerson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 3.  Bacteriophage control of bacterial virulence.

Authors:  Patrick L Wagner; Matthew K Waldor
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 4.  New insights into the haemolytic uraemic syndromes.

Authors:  D V Milford; C M Taylor
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

5.  The operator and early promoter region of the Shiga toxin type 2-encoding bacteriophage 933W and control of toxin expression.

Authors:  Jessica S Tyler; Melissa J Mills; David I Friedman
Journal:  J Bacteriol       Date:  2004-11       Impact factor: 3.490

6.  Verotoxigenic (enterohaemorrhagic) Escherichia coli in infants and toddlers in Czechoslovakia.

Authors:  M Bielaszewská; L Srámková; J Janda; K Bláhová; H Ambrozová
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

7.  Antimicrobial susceptibility of Escherichia coli O157 and other enterohaemorrhagic Escherichia coli isolated in Italy.

Authors:  C Farina; A Goglio; G Conedera; F Minelli; A Caprioli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

8.  Isolation of verotoxin-producing Escherichia coli O-rough:K1:H7 from two patients with traveler's diarrhea.

Authors:  J Vila; M Vargas; J Ruiz; F Gallardo; M T Jimenez de Anta; J Gascón
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

9.  Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.

Authors:  L L Cooling; K E Walker; T Gille; T A Koerner
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Low numbers of intestinal Shiga toxin-producing E. coli correlate with a poor prognosis in sheep infected with bovine leukemia virus.

Authors:  Witold A Ferens; Julius Haruna; Rowland Cobbold; Carolyn J Hovde
Journal:  J Vet Sci       Date:  2008-12       Impact factor: 1.672
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.